enVVeno Medical Balance Sheet Health
Financial Health criteria checks 6/6
enVVeno Medical has a total shareholder equity of $46.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $48.6M and $2.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$46.41m |
| Equity | US$46.20m |
| Total liabilities | US$2.44m |
| Total assets | US$48.64m |
Recent financial health updates
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth
Mar 07
Will enVVeno Medical (NASDAQ:NVNO) Spend Its Cash Wisely?
Aug 14Is enVVeno Medical (NASDAQ:NVNO) In A Good Position To Deliver On Growth Plans?
Apr 22We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate
Dec 21We're Hopeful That enVVeno Medical (NASDAQ:NVNO) Will Use Its Cash Wisely
Aug 23We Think enVVeno Medical (NASDAQ:NVNO) Can Afford To Drive Business Growth
May 10Recent updates
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth
Mar 07Will enVVeno Medical (NASDAQ:NVNO) Spend Its Cash Wisely?
Aug 14Is enVVeno Medical (NASDAQ:NVNO) In A Good Position To Deliver On Growth Plans?
Apr 22We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate
Dec 21enVVeno Medical: Unique Exposure To Venous Treatment Domain
Sep 23We're Hopeful That enVVeno Medical (NASDAQ:NVNO) Will Use Its Cash Wisely
Aug 23enVVeno Medical reports Q2 results
Aug 03We Think enVVeno Medical (NASDAQ:NVNO) Can Afford To Drive Business Growth
May 10We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate
Jan 25Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics
Sep 08Hancock Jaffe Laboratories finance chief sheds interim tag
Dec 31Hancock Jaffe approves 1:25 reverse stock split
Nov 27Financial Position Analysis
Short Term Liabilities: NVNO's short term assets ($46.9M) exceed its short term liabilities ($1.4M).
Long Term Liabilities: NVNO's short term assets ($46.9M) exceed its long term liabilities ($1.1M).
Debt to Equity History and Analysis
Debt Level: NVNO is debt free.
Reducing Debt: NVNO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVNO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NVNO has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 24.4% each year.